Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial

Clinical Trial Description

This study seeks to assess the tolerability of utilizing low-carbohydrate nutrition in patients admitted to the MICU with bacterial septic shock. Low carbohydrate feeds have been used before in the critical care setting and were well-tolerated. ;

Study Design

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT01164514` - Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant	Phase 1
	Completed	`NCT04517695` - Blood Volume Assessment in COVID-19 and Bacterial Sepsis

See also

Status

Clinical Trial

Phase

Terminated

NCT01164514 - Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant

Phase 1

Completed

NCT04517695 - Blood Volume Assessment in COVID-19 and Bacterial Sepsis

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03343041
Study type	Interventional
Source	Yale University
Contact
Status	Withdrawn
Phase	N/A
Start date	January 8, 2018
Completion date	June 2022

Study of Low Carbohydrate Enteral Nutrition in Patients With Bacterial Septic Shock

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms